Optimized expression cassette for expressing a polypeptide with high yield

US9663797B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9663797-B2
Application numberUS-201314443863-A
CountryUS
Kind codeB2
Filing dateNov 18, 2013
Priority dateNov 20, 2012
Publication dateMay 30, 2017
Grant dateMay 30, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is based on the finding that the combination of a specific 5′UTR polynucleotide sequence (see SEQ ID NO 1) and the hCD33 secretory leader sequence in an expression cassette for expressing a polypeptide of interest results in a surprisingly better expression level of the polypeptide of interest compared to prior art expression cassettes. Based on this finding, the present invention inter alia provides novel expression cassettes, expression vectors and methods for producing a polypeptide of interest with high yield.

First claim

Opening claim text (preview).

The invention claimed is: 1. An expression cassette suitable for expressing a polypeptide of interest comprising: a) a promoter; b) a 5′UTR polynucleotide sequence, wherein said 5′UTR polynucleotide sequence is selected from the group consisting of i) a 5′UTR polynucleotide sequence comprising the following sequence (SEQ ID NO 6) agatcgcctggagacgccatccacgctgttttgacctccatagaagacac cgggaccgatccagcctccgcggccgggaacggtgcattggaacgcggat tccccgtgccaagagtgacgtaagtaccgcctatagagtctataggccca cccccttggcttcgttagaacgcggctacaattaatacataaccttatgt atcatacacatacgatttaggtgacactatagaataacatccactttgcc tttctctccacaggtgtccactcccaggtccaactgcacctcggttctat cgaaaaacgcgtgccgccacc; and ii) a 5′UTR polynucleotide sequence comprising the following sequence (SEQ ID NO 7) agatcgcctggagacgccatccacgctgttttgacctccatagaagacac cgggaccgatccagcctccgcggccgggaacggtgcattggaacgcggat tccccgtgccaagagtgacgtaagtaccgcctatagagtctataggccca cccccttggcttcgttagaacgcggctacaattaatacataaccttatgt atcatacacatacgatttaggtgacactatagaataacatccactttgcc tttctctccacaggtgtccactcccaggtccaactgcacctcggttctat cgaaaacgcgtgccgccacc; c) a polynucleotide encoding a hCD33 secretory leader sequence; and d) a polynucleotide encoding a polypeptide of interest or an insertion site for inserting a polynucleotide encoding a polypeptide of interest. 2. The expression cassette of claim 1 , wherein the hCD33 secretory leader sequence consists of the sequence MPLLLLLPLLWAGALA (SEQ ID NO: 12). 3. The expression cassette of claim 1 , wherein said expression cassette further comprises e) a 3′UTR sequence and/or f) a poly A signal. 4. The expression cassette of claim 1 wherein the polynucleotide encoding the polypeptide of interest encodes as polypeptide of interest, two or more subunits or domains of a dimeric or multimeric protein, wherein at least one IRES element is located between the coding regions of the individual subunits or domains and each coding region is preceded by an hCD33 secretory leader sequence. 5. An expression vector for expressing a polypeptide of interest, comprising at least one expression cassette of claim 1 , additionally comprising one or more of the following elements: a) at least one expression cassette comprising a polynucleotide encoding a selectable marker; b) at least one second expression cassette for expressing a polypeptide of interest. 6. A eukaryotic host cell comprising at least one expression cassette of claim 1 . 7. The host cell of claim 6 , wherein said host cell is selected from the group consisting of rodent cells, primate cells and human cells and wherein said host cell preferably is a CHO cell. 8. A method for producing a polypeptide of interest, said method comprising culturing the eukaryotic host cells of claim 6 in a cell culture under conditions allowing expression of said polypeptide of interest. 9. The method of claim 8 , wherein said polypeptide of interest is secreted into the cell culture medium and is isolated from the cell culture medium and the isolated polypeptide is optionally further processed. 10. The method of claim 8 , wherein said polypeptide is an immunoglobulin molecule or fragment thereof. 11. The expression cassette of claim 1 , wherein the polynucleotide encoding the polypeptide of interest encodes as polypeptide of interest, two or more subunits or domains of a dimeric or multimeric protein, wherein at least one IRES element is located between the coding regions of the individual subunits or domains and each coding region is preceded by an hCD33 secretory leader sequence. 12. The expression cassette of claim 1 , wherein the expression cassette is a monocistronic expression cassette. 13. The expression cassette of claim 1 wherein the 5′UTR polynucleotide sequence comprises SEQ ID NO: 6. 14. The expression cassette of claim 1 wherein the 5′UTR polynucleotide sequence comprises SEQ ID NO: 7.

Assignees

Inventors

Classifications

  • Vector systems having a special element relevant for transcription · CPC title

  • C12N15/85Primary

    for animal cells · CPC title

  • C07K16/00Primary

    Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

  • being an enhancer not forming part of the promoter region · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9663797B2 cover?
The present invention is based on the finding that the combination of a specific 5′UTR polynucleotide sequence (see SEQ ID NO 1) and the hCD33 secretory leader sequence in an expression cassette for expressing a polypeptide of interest results in a surprisingly better expression level of the polypeptide of interest compared to prior art expression cassettes. Based on this finding, the present i…
Who is the assignee on this patent?
Dragic Zorica, Geisse Sabine, Schmitz Rita, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12N15/85. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).